AstraZeneca Other Vaccines & Immune Therapies by Quarter

Name: AstraZeneca Other Vaccines & Immune Therapies by Quarter (AZN)
Creator: AstraZeneca

Other Vaccines & Immune Therapies — Emerging Markets YoY CER (%) (%)

Quarterly Annual

AstraZeneca Other Vaccines & Immune Therapies: -26.0% in Q2 2026, down 26.0 pts from a year earlier.

Latest, Q2 2026

-26.0%

Period ended Jun 30, 2026

Change on a year earlier

-26.0 pts

0.0% in Q2 2025

History

8 quarters

Since Q2 2024

Sources

Documents cited below

Where the Q2 2026 figure comes from

“|| Other ID | | 34 | | ( 31 ) | | ( 34 ) | | ( 1 ) | | 73 | | 30 | | ( 20 ) | | ( 26 ) | | 1 | | 78 | | 69 | | 4 | | ( 68 ) | | ( 66 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Other Vaccines & Immune Therapies — Emerging Markets YoY CER (%) (%)	Year on year	Source
Q2 2026	Jun 30, 2026	-26.0%	-26.0 pts	Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026	Mar 31, 2026	-56.0%	-56.0 pts	Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025	Dec 31, 2025	-67.0%	–	Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025	Sep 30, 2025	0.0%	0.0 pts	Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025	Jun 30, 2025	0.0%	0.0 pts	Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025	Mar 31, 2025	0.0%	–	Form 6-K FY2025Q1 Earnings Release ↗
Q3 2024	Sep 30, 2024	0.0%	–	Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024	Jun 30, 2024	0.0%	–	Form 6-K FY2024Q2 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Other Vaccines & Immune Therapies (%), quarterly Q2 2024–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-vi-em-cer-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.